Corporate Film: Successful rheumatic therapy with biosimilars
Rheumatism is a disease that has many faces. There are more than a hundred different clinical pictures. Often it is difficult to identify them clearly, but it is so important that a diagnosis is made quickly. Only then rheumatologists can start a personalized treatment. Biological medicines, so-called biopharmaceutical, play an important role in the therapy. They can delay the course of the disease and, above all, relieve pain.
Filming with a patient and rheumatologist in Berlin
For the working group Pro Biosimilars we produced a corporate film about the this subject in August and September. How do biosimilars, the replicas of biopharmaceutical, influence rheumatic diseases? We met a patient in Berlin who has been ill for more than twenty years. She told us impressively how the biosimilars changed her life. We also talked to her rheumatologist who has been prescribing biopharmaceutical and biosimilars for many years.